Skip to content
DataLookout
Menu

NCT06614582

Long-term Evaluation of Nasopharyngeal Airway in Hypotonia

StatusEnrolling by Invitation
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 1 year 11 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 4 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Oct 2026 to Oct 2028 Show 4 more changesShow less
    • Eligibility criteria expanded, about 12 words
    • Primary endpoints: details revised at 1 of 2 entries
    • Secondary endpoints: details revised at 3 of 4 entries
    • Publications: details revised at 1 of 1 entry
  2. Minor Start date changed from estimate of Oct 2024 to Oct 23, 2024v3
  3. Notable Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Site contact updated
    v2
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Obstructive sleep apnea (OSA) severity measured by the apnea/hypopnea index (AHI) assessed by overnight polysomnography
Timeframe: Approximately 1 year
Long term device tolerability assessed by self-report from caregivers
Timeframe: 2 years

Secondary (4)

Long-term impact on sleep quality will be assessed by the mean score on the parent report of sleep quality
Long-term impact on daytime sleepiness will be assessed by the mean score on the children's Epworth Sleepiness Scale (ESS)
Long-term impact on quality of life will be assessed with the OSA-18
Family Impact Questionnaire (FIQ)

Arms and interventions

Self-Supporting Nasopharyngeal Airway (ssNPA)Experimental

Participants will use the device up to 24 months.

Devices: Self-Supporting Nasopharyngeal Airway (ssNPA)

Sites

1 site in 1 country

  • University of MichiganAnn Arbor, Michigan, United States